CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services.
The products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals.
The company has leading-edge expertise in image analysis, artificial intelligence and automated microscopy.
In most countries sales are via global partners. Products are sold directly in the Nordic countries and via subsidiaries in the US, Canada and Japan.
CellaVision's registered office is in Lund, Sweden. The share is listed on the Nasdaq OMX Stockholm, Small Cap list.